Metabolic Research Peptides
Metabolic peptides target incretin and fat-metabolism pathways. This category spans the GLP-1 class and related compounds studied for glucose regulation, satiety, and lipolysis.
GLP-1 is a 30-amino-acid incretin hormone that stimulates insulin secretion, suppresses glucagon, and slows gastric emptying — the foundational mechanism behind the most widely studied class of metabolic peptides.
GLP-2 T (Tirzepatide analog) is a dual GIP/GLP-1 receptor agonist demonstrating superior weight reduction in clinical trials compared to single-receptor agonists, representing the next generation of metabolic research compounds.
GLP-3 R (Retatrutide) is a triple incretin receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously — demonstrating the most significant weight reduction of any peptide class in current clinical research.
AOD-9604 is a synthetic 16-amino-acid fragment of human growth hormone (hGH176-191) that stimulates lipolysis and inhibits lipogenesis without the growth-promoting or insulin-desensitizing effects of full-length hGH.
For research and educational purposes only. These compounds are not approved for human use, and nothing here constitutes medical advice.